stars 1 stars 2 stars 3

SolveBio is the industry leader in advanced precision medicine data analytics. Its award-winning technology platform enables biopharma customers to lower trial risk, create more effective therapeutics, and compress the time scale of clinical development. The core of SolveBio’s platform is technology to connect genomic data that comes from a rapidly compounding complex landscape of vendors, studies, and patients. SolveBio is based in New York and has raised capital from Andreessen Horowitz, Max Levchin, Faridan Ventures, Flatiron Health cofounders Nat Turner and Zach Weinberg, and other leading technology and life sciences investors. SolveBio’s advisory board is made up of George Church, Joel Dudley, Yaniv Erlich, and Stephen Wolfram.

SolveBio Questions

The SolveBio annual revenue was $4 million in 2026.

1 people are employed at SolveBio.

SolveBio is based in New York City, New York.

The NAICS codes for SolveBio are [54171, 5417, 54, 541, 541713].

The SIC codes for SolveBio are [873, 87].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users